ZIM Laboratories has received approval for investment of upto Rs 40 lakh in the equity shares of SIA ZIM Laboratories, wholly owned subsidiary of the company. The investment is with an objective of expansion and development of business in the European Regions (Regulated Markets). With the proposed investment, the company’s shareholding in SIA ZIM Laboratories remains at 100%. The Board of Directors of the company in their meeting held on May 13, 2024 has inter-alia considered and approved the same.
ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develops generic pharmaceutical products.
